Showing 41 - 50 of 61,471
There are good reasons to legally regulate drugs markets, rather than persist with efforts to ban all non-medical uses of psychoactive substances. Regulated cannabis and coca markets are already a reality in several countries, with more likely to follow. But ignoring or denying that such policy...
Persistent link: https://www.econbiz.de/10012261153
IDPC was set up in 2007 as a response to the need for a global communication and advocacy structure in the area of drug policy. Since then, IDPC has become a dynamic collaborative initiative which has gradually expanded both its membership and activities to influence national and international...
Persistent link: https://www.econbiz.de/10014178815
We consider a dynamic competition game among three players, where each player can vary the extent of his competition on a per-rival basis. We call such competition targeted. We show that if the players are myopic, the weaker players eventually lose the game to their strongest rival. If instead...
Persistent link: https://www.econbiz.de/10014205539
Illicit trade has long been a central feature of Latin America’s engagement in the world. In this chapter we first briefly sketch the scope and dimensions of illicit trade in the region, and stress the importance of various types of power asymmetries. Drawing on illustrations primarily from...
Persistent link: https://www.econbiz.de/10014153646
Persistent link: https://www.econbiz.de/10014234422
Pharmaceutical drug analysis (PDA), besides quantifying drugs and related substances (RS), can enrich drug discovery (DD) by suggesting new leads. PDA may be extended towards comparative in-silico predictions for drugs and RS. This may lead to the assessment of drug likeliness of nontoxic RS as...
Persistent link: https://www.econbiz.de/10013303005
Persistent link: https://www.econbiz.de/10013533638
Persistent link: https://www.econbiz.de/10013463129
Persistent link: https://www.econbiz.de/10014273747
Persistent link: https://www.econbiz.de/10014474220